Genmab A GMAB
NASDAQ GMAB
$40.00 +0.43 (+1.09%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genmab A (GMAB) Price to Sales (2025 - 2026)

Updated

Genmab A's (GMAB) Price to Sales came in at 0.28 for the quarter ended Jun 30, 2026, down 4.7% from the prior quarter.

Analysis

Genmab A (GMAB) Price to Sales (2025 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Genmab A's Price to Sales stood at 0.53, up 20.2% from the prior year.

  • In prior years, Genmab A's Price to Sales was 0.44 in the year ended Dec 31, 2024 (-49.7%), 0.88 in the year ended Dec 31, 2023 (-36.0%), 1.38 in the year ended Dec 31, 2022 (-48.8%) and 2.69 in the year ended Dec 31, 2021 (-35.7%).
  • The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Price to Sales since the quarter ended Jun 30, 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Genmab A 2.58 Bn -2.80 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.44
Mar 31, 2026 0.48
Sep 30, 2025 0.58
Jun 30, 2025 0.42
Mar 31, 2025 0.44
API Access

Genmab A Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=GMAB&period=max&api_key=YOUR_API_KEY